ZA838092B - 5-(substituted phenyl)hydantoins - Google Patents

5-(substituted phenyl)hydantoins

Info

Publication number
ZA838092B
ZA838092B ZA838092A ZA838092A ZA838092B ZA 838092 B ZA838092 B ZA 838092B ZA 838092 A ZA838092 A ZA 838092A ZA 838092 A ZA838092 A ZA 838092A ZA 838092 B ZA838092 B ZA 838092B
Authority
ZA
South Africa
Prior art keywords
hydantoins
substituted phenyl
phenyl
substituted
Prior art date
Application number
ZA838092A
Other languages
English (en)
Inventor
James P Rizzi
Rodney C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA838092B publication Critical patent/ZA838092B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA838092A 1982-11-01 1983-10-31 5-(substituted phenyl)hydantoins ZA838092B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/438,199 US4452806A (en) 1982-11-01 1982-11-01 Treating diabetic complications with 5-(substituted phenyl)hydantoins

Publications (1)

Publication Number Publication Date
ZA838092B true ZA838092B (en) 1985-06-26

Family

ID=23739660

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA838092A ZA838092B (en) 1982-11-01 1983-10-31 5-(substituted phenyl)hydantoins

Country Status (13)

Country Link
US (1) US4452806A (fi)
JP (1) JPS5998063A (fi)
KR (1) KR860001507B1 (fi)
CA (1) CA1203241A (fi)
DK (1) DK158724C (fi)
ES (1) ES526841A0 (fi)
FI (1) FI80265C (fi)
GR (1) GR79638B (fi)
HU (1) HU191887B (fi)
PL (1) PL139646B1 (fi)
PT (1) PT77578A (fi)
YU (1) YU43556B (fi)
ZA (1) ZA838092B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1321980A4 (en) 2000-09-25 2007-04-04 Ibiden Co Ltd SEMICONDUCTOR ELEMENT, METHOD FOR MANUFACTURING SEMICONDUCTOR ELEMENT, MULTILAYER PRINTED CIRCUIT BOARD, AND METHOD FOR MANUFACTURING MULTILAYER PRINTED CIRCUIT BOARD
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814256A1 (de) * 1977-04-05 1978-10-12 Ciba Geigy Ag Schmieroelzusatzstoffe
FR2458546A1 (fr) * 1979-06-07 1981-01-02 Hoechst France Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Also Published As

Publication number Publication date
DK499983A (da) 1984-05-02
ES8507119A1 (es) 1985-05-01
FI833993A0 (fi) 1983-10-31
YU43556B (en) 1989-08-31
HU191887B (en) 1987-04-28
KR860001507B1 (ko) 1986-09-30
PL244350A1 (en) 1985-02-13
DK158724C (da) 1990-11-19
DK158724B (da) 1990-07-09
PL139646B1 (en) 1987-02-28
FI833993A (fi) 1984-05-02
US4452806A (en) 1984-06-05
ES526841A0 (es) 1985-05-01
KR840006630A (ko) 1984-12-01
DK499983D0 (da) 1983-11-01
YU216783A (en) 1986-02-28
FI80265C (fi) 1990-05-10
PT77578A (en) 1983-11-01
JPS5998063A (ja) 1984-06-06
JPH0465832B2 (fi) 1992-10-21
FI80265B (fi) 1990-01-31
GR79638B (fi) 1984-10-31
CA1203241A (en) 1986-04-15

Similar Documents

Publication Publication Date Title
GB2119801B (en) Heterocyclic compounds
EG17031A (en) Novel heterocyclic compounds
GB8315564D0 (en) Heterocyclic compounds
GB8328492D0 (en) Azole compounds
JPS56139484A (en) Heterocyclic compound
EP0094260A3 (en) Herbicidal heterocyclic alkylaminocarbonylsulfonamides
GB8300095D0 (en) Heterocyclic compounds
ZW12783A1 (en) Heterocyclic compounds
PH18045A (en) 5-(substituted phenyl)hydantoins
DE3377060D1 (en) Heterocyclic compounds
GB8304744D0 (en) Heterocyclic compounds
ZA834032B (en) Heterocyclic compounds
GB8308866D0 (en) Heterocyclic compounds
ZA838092B (en) 5-(substituted phenyl)hydantoins
DE3368614D1 (en) 5-(substituted phenyl) hydantoins
ZA831466B (en) Heterocyclic compounds
GB8310915D0 (en) Herbicidal compounds
PH18396A (en) Aldose reductase 5-(2-alkoxy-3-substituted phenyl) hydantoins
ZA834390B (en) N-sulphenylated hydantoins
ZA833328B (en) Herbicidal heterocyclic alkylaminocarbonylsulfonamides
ZA834100B (en) Heterocyclic compounds
IE822481L (en) Heterocyclic compounds
PH23088A (en) Heterocyclic compounds
ZA83308B (en) Heterocyclic compounds
IE820344L (en) Heterocyclic compounds